VX-702
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: VX-702 is a highly specific p38alpha MAPK inhibitor, 14-fold higher selectivity for... more
Product information "VX-702"
Description: VX-702 is a highly specific p38alpha MAPK inhibitor, 14-fold higher selectivity for the p38alpha than p38beta. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). Target: Autophagy, p38 MAPK. Smiles: NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F. References: Kuliopulos A, et al. Thromb Haemost, 2004, 92(6), 1387-1393.
| Keywords: | 479543-46-9 |
| Supplier: | TargetMol |
| Supplier-Nr: | T2513 |
Properties
| Application: | P38 inhibitor |
| MW: | 404.32 D |
| Formula: | C19H12F4N4O2 |
Database Information
| CAS : | 745833-23-2| Matching products |
| KEGG ID : | K04441 | Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | +20°C (International: +4°C) |
| Signal Word: | Warning |
| GHS Hazard Pictograms: |
|
| H Phrases: | H315, H319 |
| P Phrases: | P264, P280, P302+352, P305+351+338, P321, P332+313, P337+313, P362+364 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed